The international classification criteria for definite APS updated in 2006 (13) include, in addition to clinical manifestations, the presence of three subgroups of aPL: lupus anticoagulants (LA), aCL, and anti-β2-GPI, which have to be positive twice at least 12 weeks apart. The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.